1887

Abstract

A diabetic renal transplant recipient with cellulitis caused by , serotype A, is described. The diagnosis was based on the demonstration of capsulated, budding yeast cells in the aspirated material and tissue from the cellulitic lesion and isolation of the aetiological agent in culture. The isolate formed well-developed capsules in the brain tissue of experimentally infected mice and produced cherry-brown colonies on niger seed medium. The patient's serum was positive for cryptococcal antigen (titre 1 : 4) with no other evidence of systemic infection. He was successfully treated with AmBisome, followed by fluconazole, resulting in the complete resolution of cellulitis and disappearance of the cryptococcal antigen. This report underscores the fact that patients with cutaneous cryptococcosis should be thoroughly evaluated, as it may be the first manifestation of a systemic disease. Prompt diagnosis and treatment are important to improve survival.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05362-0
2004-05-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/53/5/JM530515.html?itemId=/content/journal/jmm/10.1099/jmm.0.05362-0&mimeType=html&fmt=ahah

References

  1. Abdel-Fattah A., Zeid M. S., Ghaly A. F. 1975; Primary cutaneous cryptococcosis in Egypt. Int J Dermatol 14:606–609 [CrossRef]
    [Google Scholar]
  2. Abdel-Salam H. A. 2003; Characterization of Cryptococcus neoformans var. neoformans serotype A and A/D in samples from Egypt. Folia Microbiol 48:261–268 [CrossRef]
    [Google Scholar]
  3. al-Rasheed S. A., al-Fawaz I. M. 1990; Cryptococcal meningitis in a child with systemic lupus erythematosus. Ann Trop Paediatr 10:323–326
    [Google Scholar]
  4. Anderson D. J., Schmidt C., Goodman J., Pomeroy C. 1992; Cryptococcal disease presenting as cellulitis. Clin Infect Dis 14:666–672 [CrossRef]
    [Google Scholar]
  5. Birkett D. A., McMurray J. 1976; Cutaneous cryptococcosis. Proc R Soc Med 69:515–517
    [Google Scholar]
  6. Borton L. K., Wintroub B. U. 1984; Disseminated cryptococcosis presenting as herpetiform lesions in a homosexual man with acquired immunodeficiency syndrome. J Am Acad Dermatol 10:387–390 [CrossRef]
    [Google Scholar]
  7. Campbell G. D. 1996; Primary pulmonary cryptococcosis. Am Rev Respir Dis 94:236–243
    [Google Scholar]
  8. Casadevall A., Perfect J. R. 1998 Cryptococcus neoformans Washington, DC: American Society for Microbiology;
    [Google Scholar]
  9. Chen S., Sorrell T., Nimmo G. & 7 other authors; 2000; Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand.Australasian Cryptococcal Study Group. Clin Infect Dis 31:499–508 [CrossRef]
    [Google Scholar]
  10. Christianson J. C., Engber W., Andes D. 2003; Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol 41:177–188 [CrossRef]
    [Google Scholar]
  11. Concus A. P., Helfand R. F., Imber M. J., Lerner E. A., Sharpe R. J. 1988; Cutaneous cryptococcosis mimicking molluscum contagiosum in a patient with AIDS. J Infect Dis 158:897–898 [CrossRef]
    [Google Scholar]
  12. Crounse R. G., Lerner A. B. 1958; Cryptococcosis case with unusual skin lesions and favourable response to amphotericin B therapy. Arch Dermatol 77:210–215 [CrossRef]
    [Google Scholar]
  13. Cruz M. C., Del Poeta M., Wang P. & 7 other authors; 2000; Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob Agents Chemother 44:143–149 [CrossRef]
    [Google Scholar]
  14. Cuenca-Estrella M., Diaz-Guerra T. M., Mellado E., Rodriguez-Tudela J. L. 2001; Flucytosine primary resistance in Candida species and Cryptococcus neoformans . Eur J Clin Microbiol Infect Dis 20:276–279 [CrossRef]
    [Google Scholar]
  15. Diamond R. D. 1990; Cryptococcus neoformans . In Principles and Practice of Infectious Diseases . , 3rd edn. pp 1980–1989 Edited by Mandell G. L., Douglas R. G., Bennett J. E. New York: Churchill Livingstone;
  16. Dromer F., Mathoulin S., Dupont B., Letenneur L., Ronin O. 1996; Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D.French Cryptococcosis Study Group. Clin Infect Dis 23:91–96 [CrossRef]
    [Google Scholar]
  17. Gallis H. A., Berman R. A., Cate T. R., Hamilton J. D., Gunnells J. C., Stickel D. L. 1975; Fungal infection following renal transplantation. Arch Intern Med 135:1163–1172 [CrossRef]
    [Google Scholar]
  18. Gloster H. M. Jr, Swerlick R. A., Solomon A. R. 1994; Cryptococcal cellulitis in a diabetic, kidney transplant patient. J Am Acad Dermatol 30:1025–1026 [CrossRef]
    [Google Scholar]
  19. Goonetilleke A. K., Krause K., Slater D. N., Dev D., Wood M. L., Basran G. S. 1995; Primary cutaneous cryptococcosis in an immunocompromised pigeon keeper. Br J Dermatol 133:650–652 [CrossRef]
    [Google Scholar]
  20. Hamann I. D., Gillespie R. J., Ferguson J. K. 1997; Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent host. Australas J Dermatol 38:29–32 [CrossRef]
    [Google Scholar]
  21. Handa S., Nagaraja Chakraborty A., Kumar B. 1998; Primary cutaneous cryptococcosis in an immune competent patient. J Eur Acad Dermatol Venereol 10:167–169 [CrossRef]
    [Google Scholar]
  22. Horrevorts A. M., Huysmans F. T., Koopman R. J., Meis J. F. 1994; Cellulitis as first clinical presentation of disseminated cryptococcosis in renal transplant recipients. Scand J Infect Dis 26:623–626 [CrossRef]
    [Google Scholar]
  23. Husain S., Wagener M. M., Singh N. 2001; Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 7:375–381 [CrossRef]
    [Google Scholar]
  24. Kantarcioglu A. S., Yucel A. 2002; A flucytosine-resistant Cryptococcus neoformans (serotype D) strain isolated in Turkey from cutaneous lesions. Med Mycol 40:519–523 [CrossRef]
    [Google Scholar]
  25. Khan Z. U., Pal M., Randhawa H. S., Sandhu R. S. 1978; Carriage of Cryptococcus neoformans in the crops of pigeons. J Med Microbiol 11:215–218 [CrossRef]
    [Google Scholar]
  26. Khan Z. U., Al-Anezi A. A., Chandy R., Xu J. 2003; Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii . J Med Microbiol 52:271–275 [CrossRef]
    [Google Scholar]
  27. Lazera M. S., Salmito Cavalcanti M. A., Londero A. T., Trilles L., Nishikawa M. M., Wanke B. 2000; Possible primary ecological niche of Cryptococcus neoformans . Med Mycol 38:379–383 [CrossRef]
    [Google Scholar]
  28. Li A., Nishimura K., Taguchi H., Tanaka R., Wu S., Miyaji M. 1993; The isolation of Cryptococcus neoformans from pigeon droppings and serotyping of naturally and clinically sourced isolates in China. Mycopathologia 124:1–5 [CrossRef]
    [Google Scholar]
  29. Lopez-Martinez R., Castanon-Olivares L. R. 1995; Isolation of Cryptococcus neoformans var. neoformans from bird droppings, fruits and vegetables in Mexico City. Mycopathologia 129:25–28 [CrossRef]
    [Google Scholar]
  30. Martinez L. R., Garcia-Rivera J., Casadevall A. 2001; Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C.neoformans var. grubii (serotype A) strains. J Clin Microbiol 39:3365–3367 [CrossRef]
    [Google Scholar]
  31. Mitchell T. G., Perfect J. R. 1995; Cryptococcosis in the era of AIDS–100 years after the discovery of Cryptococcus neoformans . Clin Microbiol Rev 8:515–548
    [Google Scholar]
  32. Naka W., Masuda A., Konohana A., Shinoda T., Nishikawa T. 1995; Primary cutaneous cryptococcosis and Cryptococcus neoformans serotype D. Clin Exp Dermatol 20:221–225 [CrossRef]
    [Google Scholar]
  33. Nampoory M. R. N., Khan Z. U., Johny K. V., Costandi J. N., Gupta R. K., AI-Muzairi I., Samhan M., Mozavi M., Chugh T. D. 1996; Invasive fungal infections in renal transplant recipients. J Infect 33:95–101 [CrossRef]
    [Google Scholar]
  34. NCCLS 1997 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts . Approved Standard M27A Wayne, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
  35. Neuville S., Dromer F., Morin O., Dupont B., Ronin O., Lortholary O. 2003; Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis 36:337–347 [CrossRef]
    [Google Scholar]
  36. Pal M., Mehrotra B. S. 1985; Studies on the isolation of Cryptococcus neoformans from fruits and vegetables. Mykosen 28:200–205
    [Google Scholar]
  37. Pema K., Diaz J., Guerra L. G., Nabhan D., Verghese A. 1994; Disseminated cutaneous cryptococcosis.Comparison of clinical manifestations in the pre-AIDS and AIDS eras. Arch Intern Med 154:1032–1034 [CrossRef]
    [Google Scholar]
  38. Powderly W. G. 1993; Cryptococcal meningitis and AIDS. Clin Infect Dis 17:837–842 [CrossRef]
    [Google Scholar]
  39. Randhawa H. S., Kowshik T., Khan Z. U. 2003; Decayed wood of Syzygium cumini and Ficus religiosa living trees in Delhi/New Delhi metropolitan area as natural habitat of Cryptococcus neoformans . Med Mycol 41:199–209 [CrossRef]
    [Google Scholar]
  40. Revenga F., Paricio J. F., Merino F. J., Nebreda T., Ramirez T., Martinez A. M. 2002; Primary cutaneous cryptococcosis in an immunocompetent host: case report and review of the literature. Dermatology 204:145–149 [CrossRef]
    [Google Scholar]
  41. Rook A., Woods B. 1962; Cutaneous cryptococcosis. Br J Dermatol 74:43–49 [CrossRef]
    [Google Scholar]
  42. Rubin R. H. 1988; Infection of the renal and liver transplant patient. In Clinical Approach to Infection in the Compromised Host pp 557–621 Edited by Rubin R. H., Young L. S. New York: Plenum Medical;
    [Google Scholar]
  43. Sa'adah M. A., Araj G. F., Diab S. M., Nazzal M. 1995; Cryptococcal meningitis and confusional psychosis.A case report and literature review. Trop Geogr Med 47:224–226
    [Google Scholar]
  44. Thomas I., Schwartz R. A. 2001; Cutaneous manifestations of systemic cryptococcosis in immunosuppressed patients. J Med 32:259–266
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.05362-0
Loading
/content/journal/jmm/10.1099/jmm.0.05362-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error